= Use the method       = Do not use the method   I   = Initiation of the method   C   = Continuation of the method   —   = Use the method   NA   = Not applicable Condition																		*
SYSTEMIC LUPUS ERYTHEMATOSIS
									I	C				I	C
Positive (or unknown) antiphospholipid antibodies	4		4		4		3		3	3	3		—	1	1	3		S
Severe Throbocytopenia	2		2		2		2		3	2	2		—	3	2	2		S
Immunosppresive Treatment	2		2		2		2		2	2	2		2	2	1	2		S
None of the above	2		2		2		2		2	2	2		—	1	1	2		C
NEUROLOGICAL CONDITIONS
Headachesj	I	C	I	C	I	C	I	C	I	C	I	C				I	C
Nonmigrainous (mild or severe)	1	2	1	2	1	2	1	1	1	1	1	1	—	1		1	1	A
Migraine													2
Without aura	I	C	I	C	I	C	I	C	I	C	I	C				I	C
Age < 35	2	3	2	3	2	3	1	2	2	2	2	2	—	1		2	2	A
Age ≥ 35	3	4	3	4	3	4	1	2	2	2	2	2	—	1		2	2	A
With aura, at any age	4	4	4	4	4	4	2	3	2	3	2	3	—	1		2	3	A
Epilepsy	1k		1k		1k		1k		1k		1k		—	1		1		C
DEPRESSIVE DISORDERS
Depressive disorders	1l		1l		1l		1l		1l		1l		—	1		1l		C

^j Category is for women without any other risk factors for stroke.

^k If taking anticonvulsants, refer to section on drug interactions.

^l Certain medications may interact with the method, making it less effective.

Previous Chapter   Previous Page     Next Page   Next Chapter